Editorial: CRISPR-Based Genome Editing in Translational Research—2nd Edition
Cells · 2025
DOI: 10.3390/cells15010035 ↗Kurz gefasst
Editorial in der Zeitschrift Cells, 2025. Verfasst von Jie Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Advanced Models for Translational Sciences and Therapeutics, University of Michigan Medical School, 2800 Plymouth Road, Ann Arbor, MI 4810…. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems, Translational Research, Biomedical, Clustered Regularly Interspaced Short Palindromic Repeats. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Genome editing technologies represented by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) have transformed biomedical research and therapeutic development [...]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Advanced Models for Translational Sciences and Therapeutics, University of Michigan Medical School, 2800 Plymouth Road, Ann Arbor, MI 48109, USA.
ORCID-Profile: Jie Xu
Förderung
- NIGMS NIH HHS
Zitieren
APA
Xu, J., Zhang, J., & Yang, D. (2025). Editorial: CRISPR-Based Genome Editing in Translational Research—2nd Edition. Cells. https://doi.org/10.3390/cells15010035
Vancouver
Xu J, Zhang J, Yang D. Editorial: CRISPR-Based Genome Editing in Translational Research—2nd Edition. Cells. 2025. doi:10.3390/cells15010035
BibTeX
@article{Xu2025,
author = {Xu, Jie and Zhang, Jifeng and Yang, Dongshan},
title = {Editorial: CRISPR-Based Genome Editing in Translational Research—2nd Edition},
journal = {Cells},
year = {2025},
doi = {10.3390/cells15010035}
}
EUVIMED